The Emerging Role of Estrogen Receptor 1 (ESR1) Mutations and Circulating Tumor DNA Testing in Patients With Metastatic Breast Cancer
Location: 217 - 219, Level 2
Corporate Workshop
Hosted By
Wednesday, Nov 20th
11:00 AM – 11:50 AM PST
Unlocking Efficiency and Accuracy: Sample Extraction to Multiplex Digital PCR for Oncology Research
Location: 110, Level 1
Corporate Workshop
Hosted By
Wednesday, Nov 20th
12:00 PM – 12:50 PM PST
Advancing Oncology Diagnostics: Innovative Molecular Reagents for Rapid, Accessible and Sustainable Patient-Centered Testing
Location: 208 & 209, Level 2
Corporate Workshop Speaker: Michele Amasio – Meridian Life Science
Corporate Workshop
Hosted By
Wednesday, Nov 20th
12:00 PM – 12:50 PM PST
Clinical Scenarios Demonstrating Value of NGS Using Rapid, Targeted Panel and/or More Comprehensive Approaches for Oncology Biomarker Testing of Specimens.
Fireside Chat with Market Leaders in the Liquid Biopsy Field: Bringing MRD Testing to Clinical Practice with High-quality Large-scale Sequencing at Low Cost
Location: 118, Level 1
Corporate Workshop
Hosted By
Wednesday, Nov 20th
12:00 PM – 12:50 PM PST
Identifying PIK3CA, AKT1 and PTEN-Altered HR+/HER2- Advanced Breast Cancers
Location: 217 - 219, Level 2
Corporate Workshop
Hosted By
Wednesday, Nov 20th
12:00 PM – 12:50 PM PST
Improving Liquid Biopsy Concordance Using Novel Reference Materials
Location: 220, Level 2
Corporate Workshop
Hosted By
Wednesday, Nov 20th
12:00 PM – 12:50 PM PST
Long-Range PCR Meets Long-Read Sequencing: An Assay for 11 Hard-to-Decipher, High-Frequency Carrier Screening Associated Genes
Overcoming Challenges in Congenital CMV Screening: Optimizing Laboratory Practices
Location: 205 - 207, Level 2
Corporate Workshop
Hosted By
Wednesday, Nov 20th
3:00 PM – 3:50 PM PST
Same-Day Molecular Testing Results from Cytology Specimens: The Next Frontier of Rapid On-Site Evaluation? Optimizing Small Biopsy Workflows with Idylla™